AshHill is a private investment firm with a specialized focus on the biomedical sector and participating in its portfolio companies in active management roles, as well as scientific and support services. Its mission is to discover, analyze and invest in start-up, seed-stage and established companies that are working to develop medical innovations. The firm’s leadership, including physicians, researchers, business professionals and entrepreneurs bring experience in the establishment, development, management and sale of pharmaceutical companies to optimize investments and help bring pharmaceuticals and medical devices through the regulatory process and into the marketplace. Visit www.ashhill.net for more information.